Claviwin-CF Tablet
Marketer
Kypros Pharmaceuticals
Salt Composition
Cefpodoxime Proxetil (200mg) + Clavulanic Acid (125mg)
Overview Claviwin-CF Tablet
RespiComb-Duo tablets combine two active ingredients to combat respiratory infections. This prescription medication effectively targets existing infections and inhibits microbial proliferation. Always adhere to your physician's prescribed dosage and schedule; consistent timing optimizes therapeutic impact. Never exceed the recommended dose, as overdosing may be harmful. If a dose is missed, take it immediately upon recollection. Complete the entire course of treatment, even if symptoms improve; premature cessation may compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and indigestion. Report any worsening side effects to your doctor promptly. Seek immediate medical attention for allergic reactions (e.g., rash, itching, swelling, difficulty breathing). Inform your doctor of all other medications you are taking, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to the risk of increased drowsiness. While generally safe for driving, avoid operating vehicles if experiencing drowsiness or dizziness. Adequate rest, a nutritious diet, and sufficient hydration are crucial for optimal recovery. Your doctor may order tests to monitor the medicine's effects.
Uses of Claviwin-CF Tablet
Managing infections of the respiratory system
Major Benefits of Claviwin-CF Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Claviwin-CF Tablets can be administered with or without food, however, consistent timing is recommended for optimal results.
Common Side effects of Claviwin-CF Tablet:
- Nausea
- Diarrhea
- Headache
- Rash
- Abdominal pain
- Vaginal infection
- Fungal infection of vagina
How to use Claviwin-CF Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Claviwin-CF Tablets can be consumed with or without food, however, consistent timing is recommended for optimal results.
How Claviwin-CF Tablet works:
Claviwin-CF tablets contain Cefpodoxime Proxetil, an antibiotic, and Clavulanic Acid, a beta-lactamase inhibitor. Cefpodoxime Proxetil's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial survival. Clavulanic Acid counters bacterial resistance mechanisms, thereby boosting Cefpodoxime Proxetil's effectiveness.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Claviwin-CF Tablets may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The use of Claviwin-CF Tablets during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to the fetus; however, clinical data from human trials remain scarce.
Breast feedingSAFE IF PRESCRIBED
Claviwin-CF tablets pose no known breastfeeding risk. Research in humans indicates minimal drug transfer to breast milk, presenting no apparent danger to infants.
DrivingUNSAFE
Driving ability may be impaired by Claviwin-CF Tablet side effects. These side effects can include allergic reactions, dizziness, or seizures, rendering operation of a vehicle unsafe.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Claviwin-CF Tablets; dosage modification may be necessary. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding Claviwin-CF Tablet use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Claviwin-CF Tablet :
Should you forget a Claviwin-CF Tablet dose, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Claviwin-CF Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |



